[go: up one dir, main page]

HUP0101947A2 - Tumorok kezelésére szolgáló kombinációs készítmény - Google Patents

Tumorok kezelésére szolgáló kombinációs készítmény

Info

Publication number
HUP0101947A2
HUP0101947A2 HU0101947A HUP0101947A HUP0101947A2 HU P0101947 A2 HUP0101947 A2 HU P0101947A2 HU 0101947 A HU0101947 A HU 0101947A HU P0101947 A HUP0101947 A HU P0101947A HU P0101947 A2 HUP0101947 A2 HU P0101947A2
Authority
HU
Hungary
Prior art keywords
combination
tumors
treatment
gastrin
dependent
Prior art date
Application number
HU0101947A
Other languages
English (en)
Inventor
Philip C. Gevas
Stephen Grimes
Stephen L. Karr
Dov Michaeli
Susan A. Watson
Original Assignee
Aphton Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aphton Corporation filed Critical Aphton Corporation
Publication of HUP0101947A2 publication Critical patent/HUP0101947A2/hu
Publication of HUP0101947A3 publication Critical patent/HUP0101947A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2207Gastrins; Cholecystokinins [CCK]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A találmány gasztrinfüggő tumorellenes terápiás hatóanyag-kombinációravonatkozik, amely i) egy gasztrinfüggő tumoros növekedésellenesimmunogént és ii) egy vagy több kemoterápiás anyagot tartalmaz. Ó
HU0101947A 1998-05-15 1999-05-14 Combination for the treatment of tumors HUP0101947A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8568798P 1998-05-15 1998-05-15
PCT/US1999/010750 WO1999059628A2 (en) 1998-05-15 1999-05-14 Combination therapy for the treatment of tumors

Publications (2)

Publication Number Publication Date
HUP0101947A2 true HUP0101947A2 (hu) 2001-11-28
HUP0101947A3 HUP0101947A3 (en) 2001-12-28

Family

ID=22193286

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101947A HUP0101947A3 (en) 1998-05-15 1999-05-14 Combination for the treatment of tumors

Country Status (16)

Country Link
EP (1) EP1076561B1 (hu)
JP (1) JP2002515457A (hu)
KR (1) KR100699574B1 (hu)
CN (1) CN1216605C (hu)
AT (1) ATE291918T1 (hu)
AU (1) AU745749B2 (hu)
CA (1) CA2327439C (hu)
DE (1) DE69924483T2 (hu)
DK (1) DK1076561T3 (hu)
ES (1) ES2237103T3 (hu)
HK (1) HK1032360A1 (hu)
HU (1) HUP0101947A3 (hu)
PL (1) PL193109B1 (hu)
PT (1) PT1076561E (hu)
WO (1) WO1999059628A2 (hu)
ZA (1) ZA200005962B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002252456A1 (en) * 2001-03-23 2002-10-08 Aphton Corporation Combination treatment of pancreatic cancer
JP2004536835A (ja) * 2001-07-09 2004-12-09 アフトン コーポレーション 肝臓、肺および食道の癌性ならびに前癌性状態の治療および防止
US20040208920A1 (en) * 2002-07-03 2004-10-21 Dov Michaeli Liposomal vaccine
EP1608984A2 (en) 2003-03-28 2005-12-28 Aphton Corporation Gastrin hormone immunoassays
US20050053664A1 (en) * 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
CN101797382B (zh) * 2010-03-03 2013-11-20 戚胜美 抗人前胃液素多肽免疫组合物
US8674064B2 (en) 2010-03-03 2014-03-18 Onkologix Ltd Immunogenic compositions against human progastrin peptides
EA201100464A1 (ru) * 2011-04-06 2012-10-30 Ооо "Метамакс" (Ооо "Метамах") Фармацевтическая композиция для лечения гиперпролиферативных заболеваний и её применение
RU2693484C1 (ru) 2013-11-22 2019-07-03 СиЭль БАЙОСАЕНСИЗ ЭлЭлСи Антагонисты гастрина для лечения и профилактики остеопороза
US12150978B2 (en) 2017-06-15 2024-11-26 Cancer Advances Inc. Compositions and methods for preventing tumors and cancer
WO2018232230A1 (en) 2017-06-15 2018-12-20 Cancer Advances Inc. Compositions and methods for inducing humoral and cellular immunities against tumors and cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341281C (en) * 1986-07-09 2001-08-07 Hubert J.P. Schoemaker Immunotherapy of tumor with monoclonal antibody against the 17-1a antigen
EP0380230B1 (en) * 1989-01-24 1994-11-17 Aphton Corporation Immunogenic compositions against gastrin peptides
US5468494A (en) * 1993-11-12 1995-11-21 Aphton Corp. Immunogenic compositions against human gastrin 17

Also Published As

Publication number Publication date
DE69924483D1 (de) 2005-05-04
PT1076561E (pt) 2005-08-31
EP1076561B1 (en) 2005-03-30
WO1999059628A3 (en) 2000-01-13
PL193109B1 (pl) 2007-01-31
CN1216605C (zh) 2005-08-31
KR100699574B1 (ko) 2007-03-23
ATE291918T1 (de) 2005-04-15
ES2237103T3 (es) 2005-07-16
PL344414A1 (en) 2001-11-05
ZA200005962B (en) 2002-01-24
JP2002515457A (ja) 2002-05-28
CN1303288A (zh) 2001-07-11
HK1032360A1 (en) 2001-07-20
EP1076561A2 (en) 2001-02-21
DE69924483T2 (de) 2006-02-09
AU745749B2 (en) 2002-03-28
DK1076561T3 (da) 2005-06-06
AU3904599A (en) 1999-12-06
CA2327439A1 (en) 1999-11-25
CA2327439C (en) 2005-07-05
KR20010052355A (ko) 2001-06-25
HUP0101947A3 (en) 2001-12-28
WO1999059628A2 (en) 1999-11-25

Similar Documents

Publication Publication Date Title
EP0960107A4 (hu)
PL367682A1 (en) Dolastatin 10 derivatives
DK1187632T3 (da) Behandling med anti-ErbB2-antistoffer
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
NO990789L (no) Cytotoksisk aminosukker og beslektede sukker-derivater av indolopyrrolokarbazoler
CY2295B1 (en) Phosphonooxymethyl or methylthiomethyl ethers of taxane derivatives as antitumor agents
YU76100A (sh) Pirolo(2,3-d) pirimidin preparati i njihova primena
ATE226205T1 (de) Verbindungen
ATE231872T1 (de) Thiazolopyrimidinderivate
HUP0101947A2 (hu) Tumorok kezelésére szolgáló kombinációs készítmény
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
HUP0300848A2 (hu) Kamptotecint és egy pirimidinszármazékot tartalmazó készítmény rák kezelésére
NO20005885D0 (no) Kombinasjonsterapi for behandling av refraktær depresjon
MX9601994A (es) Profarmacos de derivados de paclitaxel.
DE60040213D1 (de) Tumorimpfstoff
EE9900450A (et) Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine
DE69907926D1 (de) 1,2,4-triazol-3-thion verbindungen
HUP0104413A2 (hu) Ascomycineket tartalmazó helyi készítmények
DK1383742T3 (da) Syntese og fremgangsmåder til anvendelse af tetrahydroindolonanaloge og derivater
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
AU3439799A (en) Immunization against and treatment for infection by (h.pylori)
AP2001002369A0 (en) Pharmaceutical complex.
DE69818492D1 (en) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
HK1036070A1 (en) 5-imino-13-deoxy anthracycline derivatives, their uses and processes for preparing them.
IL160242A0 (en) Methods for the treatment and prognosis of leukemia and other cancer types

Legal Events

Date Code Title Description
FH91 Appointment of a representative

Free format text: FORMER REPRESENTATIVE(S): SZENTPETERI ZSOLT, S.B.G. & K. SZABADALMI UEGYVIVOEI IRODA, HU

Representative=s name: SZENTPETERI ZSOLT, S.B.G. & K. SZABADALMI UEGY, HU

FH92 Termination of representative

Representative=s name: SZENTPETERI ZSOLT, S.B.G. & K. SZABADALMI UEGY, HU

GB9A Succession in title

Owner name: RECEPTOR BIOLOGIX, INC., US

Free format text: FORMER OWNER(S): APHTON CORPORATION, US